ANDA 91359, held by Lannett Co Inc. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 91359 (Phentermine Hydrochloride), held by Lannett Co Inc, was first approved by FDA on Jul 16, 2010, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 16, 2010 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride30MG · capsule;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 6Labeling · Standard review | Approved | None posted |
| Dec 5, 2012 | Supplement 3Labeling · Standard review | Approved | None posted |
| Apr 19, 2012 | Supplement 1Labeling | Approved | None posted |
| Apr 19, 2012 | Supplement 2Labeling | Approved | None posted |
| Jul 16, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters